Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2016
89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau DiseaseSjoukje F Oosting, Sophie J van Asselt, Adrienne H Brouwers, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 6, 2014
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatmentSjoukje F Oosting, Adrienne H Brouwers, Suzanne C van Es, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancerKim Wopken, Hendrik P Bijl, Arjen van der Schaaf, et al.Frontiers in Immunology|September 11, 2024
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapyAnastasia Gangaev, Yannick van Sleen, Nicole Brandhorst, et al.European Urology|January 28, 2022
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaJ Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al.BMC Cancer|July 11, 2023
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designsHilin Yildirim, Christiaan V Widdershoven, Maureen Jb Aarts, et al.Head & Neck|August 11, 2016
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adultsEline Boon, Winette T A van der Graaf, Hans Gelderblom, et al.International Journal of Cancer|March 2, 2018
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The NetherlandsEline Boon, Miranda Bel, Wim van Boxtel, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2019
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinomaSarah R Verhoeff, Suzanne C van Es, Eline Boon, et al.Nature Communications|June 17, 2026
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trialSarah M H Einerhand, Hamza Ali, Stephen Q Wong, et al.Pageof 8